SZN-8141

N/A

Report date: 2025/01/22 15:59:35

Base Information

Drug NameSZN-8141

Drug Alias NameSZN-8141

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Vascular endothelial growth factorFrizzled-4 agonists

TargetsFrizzled-4Vascular endothelial growth factor

Therapy Area/IndicationsDiabetic macular oedemaMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSurrozen Inc

China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc

Inactive CompaniesN/A

Active IndicationsDiabetic macular oedemaMacular Degeneration

Inactive IndicationsN/A

Other Information

ATC CodeN/A